相关实验视频

Updated: Jan 18, 2026

Biochemical Measurement of Neonatal Hypoxia

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

基因组测序作为新生儿高 bilirubinemia 的关键初级建议:一个基于人口的多中心研究

Dabin Huang¹, Xia Gu², Weizhong Li³

¹Department of Pediatrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong 510655, China.

Journal of genetics and genomics = Yi chuan xue bao

|September 12, 2025

概括

遗传变异显著增加了新生儿高 bilirubinemia (NHB) 和相关并发症的风险. 这项研究强调了在NHB病例中需要进行基因检测,以更好地长期照顾婴儿.

科学领域:

遗传学是一个遗传学.
新生儿科学新生儿科学
儿科儿科儿科

背景情况:

新生儿高 bilirubinemia (NHB) 是婴儿住院的常见原因之一.
遗传变异作为NHB风险因素的作用及其长期影响需要进一步调查.

研究的目的:

调查遗传变异对新生儿高 bilirubinemia (NHB) 的贡献.
评估遗传变异对NHB结果的长期影响.
评估遗传变异与NHB并发症之间的关联.

主要方法:

一项基于人口的多中心研究,涉及1780名住院的NHB新生儿和38158名基因查的新生儿.
排除了具有明显临床原因的NHB病例,将977例NHB病例分为基因变异阳性和阴性组.
分析胆红素代谢途径中的基因变异,并对受影响的婴儿进行长期随访.

主要成果:

与一般新生儿人群相比,在NHB病例中观察到与NHB相关的基因变异率和阳性变异率显著更高 (P < 0.001).
具有阳性遗传变异的NHB病例显示,严重的高白血症 (16.9%对比9.7%),长期黄 (36.3%对比27.6%) 和胆/高胆血症 (23.7%对比14.7%) 的发病率更高.
UGT1A1变种与长时间的黄有关,而严重的SLC10A1变种与持久胆固醇症/高胆固醇血症有关.

结论:

遗传因素是新生儿高 bilirubinemia (NHB) 的关键决定因素.
这些发现支持将基因测试纳入NHB的新生儿护理协议.
建议对遗传变异载体进行长期监测,以改善婴儿的结果.

关键词:

遗传变异遗传变异遗传变异黄多种代谢障碍黄多种代谢障碍多中心观测多中心观测新生儿高胆红素血症新生儿高胆红素血症长时间的黄.

更多相关视频

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Isolation of Neonatal Extrahepatic Cholangiocytes

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

相关概念视频

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Maxam-Gilbert Sequencing

Maxam-Gilbert Sequencing

In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...

Sanger Sequencing

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...